FLD
Fold Holdings, Inc. Class A Common StockNASDAQFINANCIAL SERVICESCAPITAL MARKETS
Key Statistics
Market Cap
$76.22M
P/E Ratio
—
EPS
$-1.65
Beta
0.27
52W High
$5.54
52W Low
$1.00
50-Day MA
$1.36
200-Day MA
$2.79
Dividend Yield
—
Profit Margin
-218.90%
Forward P/E
—
PEG Ratio
—
About Fold Holdings, Inc. Class A Common Stock
Fold Holdings, Inc. (FLD) is a dynamic biotechnology firm focused on developing revolutionary therapies for severe genetic and rare diseases through cutting-edge research. The company boasts a promising product pipeline underpinned by proprietary technologies and strategic partnerships that enhance its competitive positioning in the market. Committed to scientific excellence and patient-centered solutions, Fold is poised for sustainable growth and value creation, making it a compelling investment opportunity in the evolving healthcare landscape.
Fundamentals
| Revenue (TTM) | $31.79M |
| Gross Profit (TTM) | $-15.59M |
| EBITDA | $-28.22M |
| Operating Margin | -90.20% |
| Return on Equity | 278.60% |
| Return on Assets | -12.80% |
| Revenue/Share (TTM) | $0.75 |
| Book Value | $1.30 |
| Price-to-Book | 1.21 |
| Price-to-Sales (TTM) | 2.40 |
| EV/Revenue | 4.631 |
| EV/EBITDA | 4.04 |
| Quarterly Earnings Growth (YoY) | 1622.00% |
| Quarterly Revenue Growth (YoY) | 41.20% |
| Shares Outstanding | $50.82M |
| Float | $5.17M |
| % Insiders | 71.32% |
| % Institutions | 15.03% |
Historical Volatility
HV 10-Day
164.91%
HV 20-Day
125.34%
HV 30-Day
148.43%
HV 60-Day
117.14%
HV Rank
88.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($3.20 target)
3
BuyData last updated: 4/29/2026